JP2013541583A5 - - Google Patents

Download PDF

Info

Publication number
JP2013541583A5
JP2013541583A5 JP2013537631A JP2013537631A JP2013541583A5 JP 2013541583 A5 JP2013541583 A5 JP 2013541583A5 JP 2013537631 A JP2013537631 A JP 2013537631A JP 2013537631 A JP2013537631 A JP 2013537631A JP 2013541583 A5 JP2013541583 A5 JP 2013541583A5
Authority
JP
Japan
Prior art keywords
ibuprofen
paracetamol
combination
composition
intravenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013537631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013541583A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NZ2011/000226 external-priority patent/WO2012060719A1/en
Publication of JP2013541583A publication Critical patent/JP2013541583A/ja
Publication of JP2013541583A5 publication Critical patent/JP2013541583A5/ja
Pending legal-status Critical Current

Links

JP2013537631A 2010-11-04 2011-10-26 組み合わせ組成物 Pending JP2013541583A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ589011 2010-11-04
NZ58901110 2010-11-04
PCT/NZ2011/000226 WO2012060719A1 (en) 2010-11-04 2011-10-26 A combination composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017055893A Division JP6353577B2 (ja) 2010-11-04 2017-03-22 組み合わせ組成物

Publications (2)

Publication Number Publication Date
JP2013541583A JP2013541583A (ja) 2013-11-14
JP2013541583A5 true JP2013541583A5 (enExample) 2014-10-09

Family

ID=46024668

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013537631A Pending JP2013541583A (ja) 2010-11-04 2011-10-26 組み合わせ組成物
JP2017055893A Active JP6353577B2 (ja) 2010-11-04 2017-03-22 組み合わせ組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017055893A Active JP6353577B2 (ja) 2010-11-04 2017-03-22 組み合わせ組成物

Country Status (28)

Country Link
US (6) US20130225685A1 (enExample)
EP (1) EP2635269B1 (enExample)
JP (2) JP2013541583A (enExample)
KR (1) KR101900520B1 (enExample)
CN (2) CN103298464A (enExample)
AU (1) AU2011324137B2 (enExample)
BR (1) BR112013010829B8 (enExample)
CA (1) CA2814057C (enExample)
CL (1) CL2013001250A1 (enExample)
CO (1) CO6771406A2 (enExample)
CY (1) CY1123398T1 (enExample)
DK (1) DK2635269T3 (enExample)
ES (1) ES2742373T3 (enExample)
HR (1) HRP20191489T1 (enExample)
HU (1) HUE045442T2 (enExample)
LT (1) LT2635269T (enExample)
MX (2) MX367209B (enExample)
MY (1) MY160572A (enExample)
NZ (1) NZ609727A (enExample)
PH (2) PH12013500689A1 (enExample)
PL (1) PL2635269T3 (enExample)
PT (1) PT2635269T (enExample)
RS (1) RS59258B1 (enExample)
RU (2) RU2707089C2 (enExample)
SG (1) SG189319A1 (enExample)
SI (1) SI2635269T1 (enExample)
SM (1) SMT201900481T1 (enExample)
WO (1) WO2012060719A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY160572A (en) 2010-11-04 2017-03-15 Aft Pharmaceuticals Ltd A combination composition
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
CA2963916A1 (en) * 2014-10-06 2016-04-14 Cumberland Pharmaceuticals, Inc. Co-administration of intravenous ibuprofen and acetaminophen for treatment of pain
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
JP7152481B2 (ja) * 2017-07-10 2022-10-12 ジェル キャップ テクノロジーズ,エルエルシー 二重放出カプセル剤形、ならびにそれを製造する方法、装置およびシステム
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11568752B2 (en) * 2020-01-28 2023-01-31 David Clark Company Incorporated Gateway retrieval alert device for aircraft pushback operations
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol
GR1010809B (el) * 2023-09-13 2024-10-25 Ιουλια Τσετη Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση
CN121285367A (zh) 2023-06-02 2026-01-06 尤利亚·采蒂 包含布洛芬的药物组合物
GR1010769B (el) * 2023-07-27 2024-09-18 Ιουλια Κλεωνος Τσετη Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3990895A (en) * 1995-12-05 1997-06-27 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
DE60114249T2 (de) * 2001-11-02 2006-05-18 Cumberland Pharmaceuticals Inc., Nashville Pharmazeutische zusammensetzung mit 2-(4-isobutylphenyl) propionsäure
CA2519772C (en) * 2003-03-21 2016-05-31 Mcneil-Ppc, Inc. Use of acetaminophen for providing a sustained therapeutic effect
PL1781277T3 (pl) * 2004-07-07 2012-07-31 Aft Pharmaceuticals Ltd Kompozycja łączona zawierająca ibuprofen i paracetamol
KR20060072839A (ko) * 2004-12-23 2006-06-28 김경태 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제
US7934627B2 (en) * 2005-10-13 2011-05-03 Alcoa Inc. Apparatus and method for high pressure extrusion with molten aluminum
AU2007309281B2 (en) * 2006-10-20 2013-10-31 Johnson & Johnson Consumer Inc. Acetaminophen / ibuprofen combinations
WO2008079818A2 (en) * 2006-12-21 2008-07-03 Soluprin Pharmaceuticals, Inc. Intravenous administration of water soluble analgesic formulations
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
TR201102810T2 (tr) * 2008-10-14 2011-05-23 Aft Pharmaceuticals Limited Tıbbi bir ürün ve tedavi
EP3417708B1 (en) * 2009-03-12 2020-06-17 Cumberland Pharmaceuticals, Inc. Administration of intravenous ibuprofen
MY164112A (en) * 2010-07-07 2017-11-30 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
MY160572A (en) 2010-11-04 2017-03-15 Aft Pharmaceuticals Ltd A combination composition
CA2963916A1 (en) * 2014-10-06 2016-04-14 Cumberland Pharmaceuticals, Inc. Co-administration of intravenous ibuprofen and acetaminophen for treatment of pain

Similar Documents

Publication Publication Date Title
JP2013541583A5 (enExample)
JP2014528474A5 (enExample)
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
JP2013155188A5 (enExample)
JP2017506624A5 (enExample)
JP2014530220A5 (enExample)
NZ597378A (en) Treatment of multiple sclerosis with laquinimod
JP2012193216A5 (enExample)
RU2015103107A (ru) Комбинированная композиция
JP2012515184A5 (enExample)
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
JP2018507243A5 (enExample)
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
PL2043637T3 (pl) Sposoby i leki do podawania ibuprofenu
JP2013518124A5 (enExample)
JP2012505830A5 (enExample)
JP2011500589A5 (enExample)
JP2016505050A5 (enExample)
JP2010500284A5 (enExample)
MX2018005298A (es) Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa.
JP2017061488A5 (enExample)
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
IL292725A (en) Benzazepines are combined for the treatment of Tourette syndrome
RU2016144695A (ru) Комплекс танната ситаглиптина
JP2014530249A5 (enExample)